JOINT FILING AGREEMENTJoint Filing Agreement • March 15th, 2019 • Puissance Life Science Opportunities Fund VI • Pharmaceutical preparations
Contract Type FiledMarch 15th, 2019 Company IndustryThe undersigned agree that this Schedule 13G, dated March 15, 2019, and any ammendments hereto, relating to the Common Shares of Scynexis, Inc. shall be filed on behalf of the undersigned.
FORM OF SUBSCRIPTION AGREEMENTSubscription Agreement • May 22nd, 2020 • Puissance Life Science Opportunities Fund VI • Pharmaceutical preparations • New York
Contract Type FiledMay 22nd, 2020 Company Industry JurisdictionNO LATER THAN ONE (1) BUSINESS DAY AFTER THE EXECUTION OF THIS AGREEMENT BY THE INVESTOR AND THE COMPANY, THE INVESTOR SHALL DIRECT THE BROKER-DEALER AT WHICH THE ACCOUNT OR ACCOUNTS TO BE CREDITED WITH THE SHARES ARE MAINTAINED TO SET UP A DEPOSIT/WITHDRAWAL AT CUSTODIAN ("DWAC") INSTRUCTING THE TRANSFER AGENT TO CREDIT SUCH ACCOUNT OR ACCOUNTS WITH THE SHARES.